Levofloxacin/Ketorolac Tromethamine

左氧氟沙星/酮咯酸氨丁三醇

Report date: 2024/10/09 20:00:32

Base Information

Drug NameLevofloxacin/Ketorolac Tromethamine
Drug Alias NameLevofloxacin; Ketorolac Trometamol 0.5+0.5% w/v Eye DropsRD03/2016
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBacterial DNA gyrase inhibitorsCyclooxygenase-1 inhibitorsCyclooxygenase-2 inhibitors
TargetsBacterial DNA gyraseTopoisomerase IICyclooxygenase-2 +[4] 
Therapy Area/IndicationsConjunctivitis, Bacterial
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryRussian FederationItalyGermany +[5] 
CombinationsYes LevofloxacinKetorolac Tromethamine
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPreclinical
Originator CompaniesZhaoke (Guangzhou) Ophthalmology Pharmaceutical Co LtdNtc
China Registration ClassN/A

Develop Information

Active CompaniesNtcNtc SrlZhaoke (Guangzhou) Ophthalmology Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsConjunctivitis, Bacterial
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A